TCL Archive NCI Pulls Back Curtain on “Zone of Uncertainty” — Funding Patterns Released With Little Comment May 4, 2012
TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive In Brief: Top Priority: Keep Rauscher; Pay Raise Bill No Moving; Miller, Holland Head AACR, ASCO May 21, 1976
TCL Archive Biggest NCI Budget Brings Large Headache: More Commitments, Rising Costs, Opportunities December 8, 1989
